RecruitingNot ApplicableNCT06972719

Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy

Patient Centered Education About Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy: a Pilot Randomized Controlled Trial

Sponsor

Duke University

Enrollment

50 participants

Start Date

Sep 30, 2025

Study Type

INTERVENTIONAL

Conditions

BRCA1 Mutation BRCA2 Mutation

Summary

The goal of this study is to develop an educational aid about hormone replacement therapy that physicians can share with patients as part of their pre-surgical counseling for a risk-reducing salpingo-oophorectomy (RRSO).

Eligibility

Sex: FEMALEMin Age: 19 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Experimental Arm and a behavioral approach called SOC Arm for people with brca1 mutation and brca2 mutation. The study is currently recruiting participants at 2 locations. People eligible for this study include women aged 19 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.